Hua Zhang, Hua Zhang, Shu Yan, Yan Zhan, Sheng Ma, Sheng Ma, . . . Liyan Miao. (2023). A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans. Frontiers Media S.A..
Chicago Style (17th ed.) CitationHua Zhang, et al. A Mass Balance Study of [14C]SHR6390 (dalpiciclib), a Selective and Potent CDK4/6 Inhibitor in Humans. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationHua Zhang, et al. A Mass Balance Study of [14C]SHR6390 (dalpiciclib), a Selective and Potent CDK4/6 Inhibitor in Humans. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.